Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Anovulation 1

Interventions

Metformin 18Inositol 5Exercise 4Pioglitazone 3Insulin 3Ethinyl Estradiol 3drospirenone and ethinyl estradiol combination 2Surveys and Questionnaires 2Cyproterone Acetate 2Acupuncture Therapy 2ziprasidone 1salicylsalicylic acid 1maltodextrin 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1Zoledronic Acid 1Waist-Hip Ratio 1Waist Circumference 1Vitamin D 1Time 1Thioctic Acid 1Tablets 1Sulfasalazine 1Sugars 1Sodium-Glucose Transporter 2 Inhibitors 1Sodium Salicylate 1Saline Solution 1Resistance Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Insulin Resistance × salicylsalicylic acid × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡